Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Enzymes used as drugs
Elapegademase
Другие языки:

    Elapegademase

    Подписчиков: 0, рейтинг: 0
    Elapegademase
    Clinical data
    Trade names Revcovi
    Other names elapegademase-lvlr
    AHFS/Drugs.com Monograph
    License data
    Routes of
    administration    		 Intramuscular
    ATC code
    Legal status
    Legal status
    Identifiers
    CAS Number
    DrugBank
    UNII
    KEGG

    Elapegademase, sold under the brand name Revcovi, is a medication for the treatment of the rare disease adenosine deaminase deficiency-SCID in children and adults.

    It is a recombinant enzyme that is administered weekly by intramuscular injection.

    Elapegademase may interact with PEGylated drugs.

    Elapegademase-lvlr was approved by the U.S. Food and Drug Administration (FDA) in 2018.Leadiant Biosciences was awarded a priority review voucher for its development under the pediatric rare diseases program.

    External links

    • "Elapegademase". Drug Information Portal. U.S. National Library of Medicine.



    Новое сообщение